Repare Therapeutics Inc reports results for the quarter ended in March - Earnings Summary

Repare Therapeutics

14/05/2021 04:01

* Repare Therapeutics Inc  RPTX.OQ  reported a quarterly
adjusted loss of 58 cents​​ per share for the quarter ended
in March. The mean expectation of five analysts for the quarter
was for a loss of 51 cents per share.
* Revenue was $166.00 thousand​;  analysts expected $625.00
thousand. 
* Repare Therapeutics Inc's reported EPS for the quarter was a
loss of 58 cents​.
* The mean earnings estimate of analysts had fallen by
about 11.2% in the last three months.​ 
* In the last 30 days there have been no earnings estimate
revisions by analysts covering the company. 
* Repare Therapeutics Inc shares had risen by 5.0% this
quarter and lost 6.1% so far this year.
* The company reported a quarterly loss of $21.42 million.
* Wall Street's median 12-month price target for Repare
Therapeutics Inc is $47.00 
* The current average analyst rating on the shares is "buy" and
the breakdown of recommendations is 6 "strong buy" or "buy," 1
"hold" and no "sell" or "strong sell." 
This summary was machine generated May 14 at 03:01 a.m. GMT.
​All figures in US dollars